Advertisement
Canada markets open in 1 hour 10 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7311
    +0.0013 (+0.18%)
     

  • CRUDE OIL

    83.15
    +0.34 (+0.41%)
     

  • Bitcoin CAD

    87,553.06
    -3,665.89 (-4.02%)
     

  • CMC Crypto 200

    1,355.66
    -26.91 (-1.95%)
     

  • GOLD FUTURES

    2,340.20
    +1.80 (+0.08%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,477.75
    -186.75 (-1.06%)
     

  • VOLATILITY

    16.32
    +0.35 (+2.19%)
     

  • FTSE

    8,097.83
    +57.45 (+0.71%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

Should You Get Rid of Dun & Bradstreet Corp. (DNB) Now?

Zacks Equity Research
Updated

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.

One such stock that you may want to consider dropping is The Dun & Bradstreet Corporation DNB, which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. A Zacks Rank #5 (Strong Sell) further confirms weakness in DNB.

A key reason for this move has been the negative trend in earnings estimate revisions. For the full year, we have seen six estimates moving down in the past 30 days, compared with no upward revision. This trend has caused the consensus estimate to trend lower, going from $7.70 a share a month ago to its current level of $6.98.

Also, for the current quarter, Dun & Bradstreet Corp.has seen four downward estimate revisions versus no revision in the opposite direction, dragging the consensus estimate down to 89 cents a share from $1.20 over the past 30 days.  

ADVERTISEMENT

The stock also has seen some pretty dismal trading lately, as the share price has dropped 11.7% in the past month.

Dun & Bradstreet Corporation (The) Price and Consensus

Dun & Bradstreet Corporation (The) Price and Consensus | Dun & Bradstreet Corporation (The) Quote

So it may not be a good decision to keep this stock in your portfolio anymore, at least if you don’t have a long time horizon to wait.

If you are still interested in the Business - Information Services industry, you may instead consider a better-ranked stock - National Research Corporation NRCIB. The stock currently holds a Zacks Rank #1 (Strong Buy) and may be a better selection at this time. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Best Place to Start Your Stock Search

Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buy" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research. See these stocks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Dun & Bradstreet Corporation (The) (DNB): Free Stock Analysis Report
 
National Research Corporation (NRCIB): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research